Kostenuik PJ et al. |
OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats. |
2001 |
Endocrinology |
pmid:11564687
|
Seidel C et al. |
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. |
2001 |
Blood |
pmid:11568016
|
Yan T et al. |
Regulation of osteoclastogenesis and RANK expression by TGF-beta1. |
2001 Aug 1-9 |
J. Cell. Biochem. |
pmid:11573248
|
Fukagawa M et al. |
Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. |
2001 |
Am. J. Kidney Dis. |
pmid:11576943
|
Sato T et al. |
Osteoprotegerin levels before and after renal transplantation. |
2001 |
Am. J. Kidney Dis. |
pmid:11576949
|
Feuerherm AJ et al. |
Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. |
2001 |
Scand. J. Rheumatol. |
pmid:11578019
|
Quinn JM et al. |
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. |
2001 |
J. Bone Miner. Res. |
pmid:11585342
|
Choi SJ et al. |
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment. |
2001 |
J. Bone Miner. Res. |
pmid:11585344
|
Miyamoto T et al. |
Bifurcation of osteoclasts and dendritic cells from common progenitors. |
2001 |
Blood |
pmid:11588053
|
Satoh K et al. |
Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. |
2001 |
Pancreas |
pmid:11590320
|